2026 Blue Rx PDP Plus (PDP) formulary (drug list)
Contract S5593, plan 002 · West Virginia · 3,788 drugs on file · formulary ID 00026017. Each drug links to its cost in every CMS PDP Region 06 plan.
180 drugs starting with E.
| Drug name | Tier | 30-day preferred pharmacy | 90-day mail order | Usage management |
|---|---|---|---|---|
| ECONAZOLE NITRATE 10 mg/g Cream | 2Generic | 25% | 25% |
|
| EDARBYCLOR 40/12.5 mg TabletAzilsartan Kamedoxomil And Chlorthalidone | 4Non-Preferred Drug | 25% | 25% | None |
| EDARBYCLOR 40/25 mg TabletAzilsartan Kamedoxomil And Chlorthalidone | 4Non-Preferred Drug | 25% | 25% | None |
| EDURANT 25 mg Tablet, Film CoatedRilpivirine Hydrochloride | 5Specialty Tier | 25% | 25% | None |
| EDURANT PED 2.5 mg Tablet, For SuspensionRilpivirine Hydrochloride | 5Specialty Tier | 25% | 25% | None |
| EFAVIRENZ 600 mg Tablet, Film Coated | 3Preferred Brand | 25% | 25% | None |
| EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 600/200/300 mg Tablet, Film Coated | 5Specialty Tier | 25% | 25% | None |
| EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 400/300/300 mg Tablet, Film Coated | 5Specialty Tier | 25% | 25% |
|
| EFAVIRENZ, LAMIVUDINE AND TENOFOVIR DISOPROXIL FUMARATE 600/300/300 mg Tablet, Film Coated | 5Specialty Tier | 25% | 25% |
|
| ELETRIPTAN HYDROBROMIDE 20 mg Tablet, Film Coated | 4Non-Preferred Drug | 25% | 25% |
|
| ELETRIPTAN HYDROBROMIDE 40 mg Tablet, Film Coated | 4Non-Preferred Drug | 25% | 25% |
|
| ELIGARD 45 mg/.375mL Injection, Suspension, Extended ReleaseLeuprolide Acetate | 4Non-Preferred Drug | 25% | 25% |
|
| ELIGARD KitLeuprolide Acetate | 4Non-Preferred Drug | 25% | 25% |
|
| ELIGARD KitLeuprolide Acetate | 4Non-Preferred Drug | 25% | 25% |
|
| ELIGARD KitLeuprolide Acetate | 4Non-Preferred Drug | 25% | 25% |
|
| ELIQUIS 2.5 mg Tablet, Film CoatedApixaban | 3Preferred Brand | 25% | 25% |
|
| ELIQUIS 30-DAY STARTER PACK KitApixaban | 3Preferred Brand | 25% | 25% |
|
| ELIQUIS 5 mg Tablet, Film CoatedApixaban | 3Preferred Brand | 25% | 25% |
|
| ELMIRON 100 mg Capsule, Gelatin CoatedPentosan Polysulfate Sodium | 4Non-Preferred Drug | 25% | 25% | None |
| ELTROMBOPAG 12.5 mg Powder, For SuspensionEltrombopag Olamine | 5Specialty Tier | 25% | 25% |
|
| ELTROMBOPAG 12.5 mg Tablet, Film Coated | 5Specialty Tier | 25% | 25% |
|
| ELTROMBOPAG 25 mg Powder, For SuspensionEltrombopag Olamine | 5Specialty Tier | 25% | 25% |
|
| ELTROMBOPAG 25 mg Tablet, Film Coated | 5Specialty Tier | 25% | 25% |
|
| ELTROMBOPAG 50 mg Tablet, Film Coated | 5Specialty Tier | 25% | 25% |
|
| ELTROMBOPAG 75 mg Tablet, Film Coated | 5Specialty Tier | 25% | 25% |
|
| ELURYNG .12/.015 mg/d RingEtonogestrel And Ethinyl Estradiol | 3Preferred Brand | 25% | 25% | None |
| EMEND 125 mg Powder, For SuspensionAprepitant | 4Non-Preferred Drug | 25% | 25% |
|
| EMGALITY 100 mg/mL Injection, SolutionGalcanezumab-Gnlm | 5Specialty Tier | 25% | 25% |
|
| EMGALITY 120 mg/mL Injection, SolutionGalcanezumab-Gnlm | 3Preferred Brand | 25% | 25% |
|
| EMGALITY 120 mg/mL Injection, SolutionGalcanezumab-Gnlm | 3Preferred Brand | 25% | 25% |
|
| EMSAM 12 mg/24h PatchSelegiline | 5Specialty Tier | 25% | 25% |
|
| EMSAM 6 mg/24h PatchSelegiline | 5Specialty Tier | 25% | 25% |
|
| EMSAM 9 mg/24h PatchSelegiline | 5Specialty Tier | 25% | 25% |
|
| EMTRICITABINE 200 mg Capsule | 4Non-Preferred Drug | 25% | 25% | None |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 100/150 mg Tablet, Film Coated | 4Non-Preferred Drug | 25% | 25% | None |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 133/200 mg Tablet, Film Coated | 5Specialty Tier | 25% | 25% | None |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 167/250 mg Tablet, Film Coated | 4Non-Preferred Drug | 25% | 25% | None |
| EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE 200/300 mg Tablet, Film Coated | 4Non-Preferred Drug | 25% | 25% | None |
| EMTRICITABINE, RILPIVIRINE, TENOFOVIR DISOPROXIL FUMARATE 200/25/300 mg Tablet, Film Coated | 5Specialty Tier | 25% | 25% | None |
| EMTRIVA 10 mg/mL SolutionEmtricitabine | 3Preferred Brand | 25% | 25% | None |
| ENALAPRIL MALEATE 10 mg Tablet | 1Preferred Generic | 25% | 25% | None |
| ENALAPRIL MALEATE 2.5 mg Tablet | 1Preferred Generic | 25% | 25% | None |
| ENALAPRIL MALEATE 20 mg Tablet | 1Preferred Generic | 25% | 25% | None |
| ENALAPRIL MALEATE 5 mg Tablet | 1Preferred Generic | 25% | 25% | None |
| ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE 10/25 mg Tablet | 1Preferred Generic | 25% | 25% | None |
| ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE 5/12.5 mg Tablet | 1Preferred Generic | 25% | 25% | None |
| ENALAPRIL MALEATE ORAL SOLUTION 1 mg/mL SolutionEnalapril Maleate | 4Non-Preferred Drug | 25% | 25% | None |
| ENBREL 25 mg/.5mL SolutionEtanercept | 5Specialty Tier | 25% | 25% |
|
| ENBREL 25 mg/.5mL SolutionEtanercept | 5Specialty Tier | 25% | 25% |
|
| ENBREL 50 mg/mL SolutionEtanercept | 5Specialty Tier | 25% | 25% |
|
| ENBREL 50 mg/mL SolutionEtanercept | 5Specialty Tier | 25% | 25% |
|
| ENBREL 50 mg/mL SolutionEtanercept | 5Specialty Tier | 25% | 25% |
|
| ENGERIX-B 10 ug/.5mL Injection, SuspensionHepatitis B Vaccine (Recombinant) | 3Preferred Brand | 25% | 25% |
|
| ENGERIX-B 20 ug/mL Injection, SuspensionHepatitis B Vaccine (Recombinant) | 3Preferred Brand | 25% | 25% |
|
| ENOXAPARIN SODIUM 100 mg/mL Injection | 2Generic | 25% | 25% | None |
| ENOXAPARIN SODIUM 100 mg/mL Injection | 2Generic | 25% | 25% | None |
| ENOXAPARIN SODIUM 100 mg/mL Injection | 2Generic | 25% | 25% | None |
| ENOXAPARIN SODIUM 100 mg/mL Injection | 4Non-Preferred Drug | 25% | 25% | None |
| ENOXAPARIN SODIUM 100 mg/mL Injection | 2Generic | 25% | 25% | None |
| ENOXAPARIN SODIUM 150 mg/mL Injection | 4Non-Preferred Drug | 25% | 25% | None |
| ENOXAPARIN SODIUM 150 mg/mL Injection | 4Non-Preferred Drug | 25% | 25% | None |
| ENSACOVE 100 mg CapsuleEnsartinib | 5Specialty Tier | 25% | 25% |
|
| ENSACOVE 25 mg CapsuleEnsartinib | 5Specialty Tier | 25% | 25% |
|
| ENSKYCE KitDesogestrel And Ethinyl Estradiol | 2Generic | 25% | 25% | None |
| ENTACAPONE 200 mg Tablet | 2Generic | 25% | 25% | None |
| ENTECAVIR .5 mg Tablet | 4Non-Preferred Drug | 25% | 25% | None |
| ENTECAVIR 1 mg Tablet | 4Non-Preferred Drug | 25% | 25% | None |
| ENTRESTO 15/16 mg PelletSacubitril And Valsartan | 3Preferred Brand | 25% | 25% |
|
| ENTRESTO 24/26 mg Tablet, Film CoatedSacubitril And Valsartan | 4Non-Preferred Drug | 25% | 25% |
|
| ENTRESTO 49/51 mg Tablet, Film CoatedSacubitril And Valsartan | 4Non-Preferred Drug | 25% | 25% |
|
| ENTRESTO 6/6 mg PelletSacubitril And Valsartan | 3Preferred Brand | 25% | 25% |
|
| ENTRESTO 97/103 mg Tablet, Film CoatedSacubitril And Valsartan | 4Non-Preferred Drug | 25% | 25% |
|
| ENULOSE 10 g/15mL SolutionLactulose | 2Generic | 25% | 25% | None |
| ENVARSUS XR .75 mg Tablet, Extended ReleaseTacrolimus | 4Non-Preferred Drug | 25% | 25% |
|
| ENVARSUS XR 1 mg Tablet, Extended ReleaseTacrolimus | 4Non-Preferred Drug | 25% | 25% |
|
| ENVARSUS XR 4 mg Tablet, Extended ReleaseTacrolimus | 5Specialty Tier | 25% | 25% |
|
| EOHILIA 2 mg/10mL SuspensionBudesonide | 5Specialty Tier | 25% | 25% |
|
| EPIDIOLEX 100 mg/mL SolutionCannabidiol | 5Specialty Tier | 25% | 25% |
|
| EPINASTINE HYDROCHLORIDE .5 mg/mL Solution/ Drops | 2Generic | 25% | 25% | None |
| EPINEPHRINE .15 mg/.15mL Injection | 3Preferred Brand | 25% | 25% | None |
| EPINEPHRINE .15 mg/.3mL Injection | 3Preferred Brand | 25% | 25% | None |
| EPINEPHRINE .3 mg/.3mL Injection | 3Preferred Brand | 25% | 25% | None |
| EPINEPHRINE .3 mg/.3mL Injection | 3Preferred Brand | 25% | 25% | None |
| EPLERENONE 25 mg Tablet, Film Coated | 2Generic | 25% | 25% | None |
| EPLERENONE 50 mg Tablet, Film Coated | 2Generic | 25% | 25% | None |
| EQUETRO 100 mg Capsule, Extended ReleaseCarbamazepine | 4Non-Preferred Drug | 25% | 25% | None |
| EQUETRO 200 mg Capsule, Extended ReleaseCarbamazepine | 4Non-Preferred Drug | 25% | 25% | None |
| EQUETRO 300 mg Capsule, Extended ReleaseCarbamazepine | 4Non-Preferred Drug | 25% | 25% | None |
| ERAXIS 100 mg/30mL Injection, Powder, Lyophilized, For SolutionAnidulafungin | 5Specialty Tier | 25% | 25% | None |
| ERAXIS 50 mg/15mL Injection, Powder, Lyophilized, For SolutionAnidulafungin | 4Non-Preferred Drug | 25% | 25% | None |
| ERGOTAMINE TARTRATE AND CAFFEINE 1/100 mg Tablet, Film Coated | 3Preferred Brand | 25% | 25% |
|
| ERIVEDGE 150 mg CapsuleVismodegib | 5Specialty Tier | 25% | 25% |
|
| ERLEADA 240 mg Tablet, Film CoatedApalutamide | 5Specialty Tier | 25% | 25% |
|
| ERLEADA 60 mg Tablet, Film CoatedApalutamide | 5Specialty Tier | 25% | 25% |
|
| ERLOTINIB 100 mg Tablet, Film Coated | 5Specialty Tier | 25% | 25% |
|
| ERLOTINIB 150 mg Tablet, Film Coated | 5Specialty Tier | 25% | 25% |
|
| ERLOTINIB 25 mg Tablet | 5Specialty Tier | 25% | 25% |
|
| ERTAPENEM 1 g/20mL InjectionErtapenem Sodium | 4Non-Preferred Drug | 25% | 25% | None |
| ERY 20 mg/mL SwabErythromycin | 2Generic | 25% | 25% | None |
| ERYTHROMYCIN 20 mg/g Gel | 2Generic | 25% | 25% |
|
| ERYTHROMYCIN 20 mg/mL Solution | 2Generic | 25% | 25% |
|
| ERYTHROMYCIN 250 mg Tablet, Coated | 4Non-Preferred Drug | 25% | 25% | None |
| ERYTHROMYCIN 5 mg/g Ointment | 2Generic | 25% | 25% | None |
| ERYTHROMYCIN 500 mg Tablet, Coated | 4Non-Preferred Drug | 25% | 25% | None |
| ERYTHROMYCIN AND BENZOYL PEROXIDE 30/50 mg/g Gel | 2Generic | 25% | 25% | None |
| ESCITALOPRAM 10 mg Tablet, Film Coated | 2Generic | 25% | 25% |
|
| ESCITALOPRAM 15 mg Capsule | 4Non-Preferred Drug | 25% | 25% |
|
| ESCITALOPRAM 20 mg Tablet, Film Coated | 2Generic | 25% | 25% |
|
| ESCITALOPRAM 5 mg Tablet, Film Coated | 2Generic | 25% | 25% |
|
| ESCITALOPRAM OXALATE 5 mg/5mL SolutionEscitalopram | 4Non-Preferred Drug | 25% | 25% |
|
| ESLICARBAZEPINE ACETATE 200 mg Tablet | 4Non-Preferred Drug | 25% | 25% |
|
| ESLICARBAZEPINE ACETATE 400 mg Tablet | 5Specialty Tier | 25% | 25% |
|
| ESLICARBAZEPINE ACETATE 600 mg Tablet | 5Specialty Tier | 25% | 25% |
|
| ESLICARBAZEPINE ACETATE 800 mg Tablet | 5Specialty Tier | 25% | 25% |
|
| ESOMEPRAZOLE MAGNESIUM 20 mg Capsule, Delayed Release | 2Generic | 25% | 25% |
|
| ESOMEPRAZOLE MAGNESIUM 40 mg Capsule, Delayed Release | 2Generic | 25% | 25% |
|
| ESTARYLLA KitNorgestimate And Ethinyl Estradiol | 2Generic | 25% | 25% | None |
| ESTAZOLAM 1 mg Tablet | 2Generic | 25% | 25% |
|
| ESTAZOLAM 2 mg Tablet | 2Generic | 25% | 25% |
|
| ESTRADIOL .025 mg/d Patch | 2Generic | 25% | 25% | None |
| ESTRADIOL .025 mg/d Patch | 2Generic | 25% | 25% | None |
| ESTRADIOL .0375 mg/d Patch | 2Generic | 25% | 25% | None |
| ESTRADIOL .0375 mg/d Patch | 2Generic | 25% | 25% | None |
| ESTRADIOL .05 mg/d Patch | 2Generic | 25% | 25% | None |
| ESTRADIOL .05 mg/d Patch | 2Generic | 25% | 25% | None |
| ESTRADIOL .06 mg/d Patch | 2Generic | 25% | 25% | None |
| ESTRADIOL .075 mg/d Patch | 2Generic | 25% | 25% | None |
| ESTRADIOL .075 mg/d Patch | 2Generic | 25% | 25% | None |
| ESTRADIOL .1 mg/d Patch | 2Generic | 25% | 25% | None |
| ESTRADIOL .1 mg/d Patch | 2Generic | 25% | 25% | None |
| ESTRADIOL .5 mg Tablet | 1Preferred Generic | 25% | 25% | None |
| ESTRADIOL / NORETHINDRONE ACETATE .5/.1 mg Tablet, Film CoatedEstradiol And Norethindrone Acetate | 2Generic | 25% | 25% | None |
| ESTRADIOL / NORETHINDRONE ACETATE 1/.5 mg Tablet, Film CoatedEstradiol And Norethindrone Acetate | 2Generic | 25% | 25% | None |
| ESTRADIOL 1 mg Tablet | 1Preferred Generic | 25% | 25% | None |
| ESTRADIOL 10 ug Insert | 4Non-Preferred Drug | 25% | 25% | None |
| ESTRADIOL 2 mg Tablet | 1Preferred Generic | 25% | 25% | None |
| ESTRADIOL VAGINAL .1 mg/g CreamEstradiol | 4Non-Preferred Drug | 25% | 25% | None |
| ESTRING 2 mg SystemEstradiol | 4Non-Preferred Drug | 25% | 25% | None |
| ESZOPICLONE 1 mg Tablet, Film Coated | 2Generic | 25% | 25% |
|
| ESZOPICLONE 2 mg Tablet, Film Coated | 2Generic | 25% | 25% |
|
| ESZOPICLONE 3 mg Tablet, Film Coated | 2Generic | 25% | 25% |
|
| ETHACRYNIC ACID 25 mg Tablet | 4Non-Preferred Drug | 25% | 25% | None |
| ETHAMBUTOL HYDROCHLORIDE 100 mg Tablet | 2Generic | 25% | 25% | None |
| ETHAMBUTOL HYDROCHLORIDE 400 mg Tablet | 2Generic | 25% | 25% | None |
| ETHOSUXIMIDE 250 mg/5mL Solution | 2Generic | 25% | 25% | None |
| ETODOLAC 200 mg Capsule | 3Preferred Brand | 25% | 25% | None |
| ETODOLAC 300 mg Capsule | 3Preferred Brand | 25% | 25% | None |
| ETODOLAC 400 mg Tablet, Extended Release | 3Preferred Brand | 25% | 25% | None |
| ETODOLAC 400 mg Tablet, Film Coated | 2Generic | 25% | 25% | None |
| ETODOLAC 500 mg Tablet, Extended Release | 3Preferred Brand | 25% | 25% | None |
| ETODOLAC 500 mg Tablet, Film Coated | 2Generic | 25% | 25% | None |
| ETODOLAC 600 mg Tablet, Film Coated, Extended Release | 3Preferred Brand | 25% | 25% | None |
| ETONOGESTREL/ETHINYL ESTRADIOL .12/.015 mg/d Insert, Extended ReleaseEtonogestrel And Ethinyl Estradiol | 3Preferred Brand | 25% | 25% | None |
| ETRAVIRINE 100 mg Tablet | 5Specialty Tier | 25% | 25% | None |
| ETRAVIRINE 200 mg Tablet | 5Specialty Tier | 25% | 25% | None |
| EULEXIN 125 mg CapsuleFlutamide | 4Non-Preferred Drug | 25% | 25% | None |
| EVAMIST 1.53 mg SprayEstradiol | 4Non-Preferred Drug | 25% | 25% | None |
| EVEROLIMUS .25 mg Tablet | 4Non-Preferred Drug | 25% | 25% |
|
| EVEROLIMUS .5 mg Tablet | 5Specialty Tier | 25% | 25% |
|
| EVEROLIMUS .75 mg Tablet | 5Specialty Tier | 25% | 25% |
|
| EVEROLIMUS 1 mg Tablet | 5Specialty Tier | 25% | 25% |
|
| EVEROLIMUS 10 mg Tablet | 5Specialty Tier | 25% | 25% |
|
| EVEROLIMUS 2 mg Tablet, For Suspension | 5Specialty Tier | 25% | 25% |
|
| EVEROLIMUS 2.5 mg Tablet | 5Specialty Tier | 25% | 25% |
|
| EVEROLIMUS 3 mg Tablet, For Suspension | 5Specialty Tier | 25% | 25% |
|
| EVEROLIMUS 5 mg Tablet | 5Specialty Tier | 25% | 25% |
|
| EVEROLIMUS 5 mg Tablet, For Suspension | 5Specialty Tier | 25% | 25% |
|
| EVEROLIMUS 7.5 mg Tablet | 5Specialty Tier | 25% | 25% |
|
| EVOTAZ 300/150 mg TabletAtazanavir And Cobicistat | 5Specialty Tier | 25% | 25% | None |
| EXEMESTANE 25 mg Tablet | 2Generic | 25% | 25% | None |
| EXXUA 18.2 mg Tablet, Extended ReleaseGepirone | 4Non-Preferred Drug | 25% | 25% |
|
| EXXUA 18.2 mg Tablet, Extended ReleaseGepirone | 4Non-Preferred Drug | 25% | 25% |
|
| EXXUA 36.3 mg Tablet, Extended ReleaseGepirone | 4Non-Preferred Drug | 25% | 25% |
|
| EXXUA 54.5 mg Tablet, Extended ReleaseGepirone | 4Non-Preferred Drug | 25% | 25% |
|
| EXXUA 72.6 mg Tablet, Extended ReleaseGepirone | 4Non-Preferred Drug | 25% | 25% |
|
| EZETIMIBE 10 mg Tablet | 2Generic | 25% | 25% | None |
| EZETIMIBE AND SIMVASTATIN 10/10 mg Tablet | 3Preferred Brand | 25% | 25% |
|
| EZETIMIBE AND SIMVASTATIN 10/20 mg Tablet | 3Preferred Brand | 25% | 25% |
|
| EZETIMIBE AND SIMVASTATIN 10/40 mg Tablet | 3Preferred Brand | 25% | 25% |
|
| EZETIMIBE AND SIMVASTATIN 10/80 mg Tablet | 3Preferred Brand | 25% | 25% |
|
PA = prior authorization, ST = step therapy, QL = quantity limit. Costs are the plan’s initial-coverage cost-sharing from the CMS 2026 formulary files; a drug not listed here is not on this plan’s formulary, though a formulary exception may still be possible.